However, it has also been reported that the treatment of prostate cancer cells with TGF-β results in translocation of PHB from the nucleus to the cytosol where it strongly associates with the mitochondrial apoptosis-suppressor Bcl-2 and represses its activity [53]. Here, TGFB1 is linked to prostate cancer.